Real-time enrollment status for this atherosclerosis clinical trial
Current Status
Recruiting
Checked: September 23, 2026 at 4:08 AM UTC
| NCT Number | NCT07783802 |
| Recruiting Status | Recruiting |
| Condition | Atherosclerosis |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | September 22, 2026 (Yesterday) |
As of September 23, 2026: Clinical trial NCT07783802 is currently recruiting participants. This phase2 study for atherosclerosis is actively seeking new participants at 30 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07783802 is actively recruiting participants as of September 23, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07783802 was last updated Yesterday (September 22, 2026). HelloStudys verifies this status automatically.